Mark A. Behlke

Mark A. Behlke

Chief Tech/Sci/R&D Officer at Integrated DNA Technologies, Inc.

Health Technology
Process Industries
Finance

Profile

Mark A.
Behlke
is the founder of Dicerna Pharmaceuticals, Inc. which was founded in 2007.
He is currently the Chief Scientific Officer at Integrated DNA Technologies, Inc. Dr. Behlke has a doctorate degree from Washington University in St. Louis which he received in 1988 and an undergraduate degree from Massachusetts Institute of Technology which he received in 1981.

Mark A. Behlke active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer -
All active positions of Mark A. Behlke

Former positions of Mark A. Behlke

Training of Mark A. Behlke

Massachusetts Institute of Technology Undergraduate Degree
Washington University in St. Louis Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark A. Behlke's experience

Connections

100 +

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies2

Health Technology

Process Industries

See company connections
  1. Stock Market
  2. Insiders
  3. Mark A. Behlke